Ocular Hypertension

Showing NaN - NaN of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Safety Study of Bimatoprost Intracameral Implant (DURYSTA)

Recruiting
  • Open-angle Glaucoma
  • Ocular Hypertension
    • Culver City, California
    • +24 more
    Feb 21, 2022

    Open Angle Glaucoma, Ocular Hypertension Trial in United States (Brimonidine Tartrate Ophthalmic Suspension, Brimonidine

    Completed
    • Open Angle Glaucoma
    • Ocular Hypertension
    • Brimonidine Tartrate Ophthalmic Suspension
    • Brimonidine Tartrate Ophthalmic Solution
    • Chandler, Arizona
    • +46 more
    Jan 27, 2022

    Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham: Applicator Without Needle, Active

    Completed
    • Glaucoma, Open-Angle
    • Ocular Hypertension
    • Bimatoprost SR
    • +3 more
    • Dothan, Alabama
    • +112 more
    Jul 6, 2021

    Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,

    Completed
    • Primary Open-Angle Glaucoma
    • Ocular Hypertension
    • PF-04217329 - Lowest Dose
    • +8 more
    • Artesia, California
    • +22 more
    Apr 6, 2021

    Glaucoma, Open-Angle, Ocular Hypertension Trial in Canada, United States (Xalacom, Xalatan, Timolol)

    Completed
    • Glaucoma, Open-Angle
    • Ocular Hypertension
    • Phoenix, Arizona
    • +54 more
    Feb 17, 2021

    Ocular Hypertension, Glaucoma Trial in United States (latanoprost 0.005%, fixed combination latanoprost-timolol, timolol 0.5%)

    Completed
    • Ocular Hypertension
    • Glaucoma
    • latanoprost 0.005%
    • +2 more
    • Anaheim, California
    • +52 more
    Feb 17, 2021

    Glaucoma, Ocular Hypertension Trial in United States (latanoprost 0.005% ophthalmic solution, Travoprost 004% sterile ophthalmic

    Completed
    • Glaucoma
    • Ocular Hypertension
    • latanoprost 0.005% ophthalmic solution
    • +2 more
    • Bellflower, California
    • +39 more
    Feb 1, 2021

    Glaucoma, Ocular Hypertension Trial in United States (RKI983A, Latanoprost)

    Completed
    • Glaucoma
    • Ocular Hypertension
    • Artesia, California
    • +28 more
    Dec 11, 2020

    Primary Open Angle Glaucoma, Ocular Hypertension, Pigmentary Glaucoma Trial in United States (PF-03187207 and Latanoprost

    Completed
    • Primary Open Angle Glaucoma
    • +3 more
    • PF-03187207 and Latanoprost Vehicle
    • Latanoprost 0.005% and PF-03187207 Vehicle
    • Artesia, California
    • +18 more
    Sep 10, 2020

    Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (bimatoprost 20 µg generation 2, bimatoprost 15 µg generation 2,

    Completed
    • Open-Angle Glaucoma
    • Ocular Hypertension
    • bimatoprost 20 µg generation 2
    • +6 more
    • Artesia, California
    • +56 more
    Mar 27, 2020

    Glaucoma, Ocular Hypertension Trial in Atlanta (bimatoprost eye drops, )

    Completed
    • Glaucoma
    • Ocular Hypertension
    • bimatoprost eye drops
    • placebo
    • Atlanta, Georgia
      (unnamed)
    Apr 10, 2019

    Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)

    Completed
    • Primary Open-Angle Glaucoma
    • Ocular Hypertension
    • Artesia, California
    • +9 more
    Feb 1, 2019

    Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Eye Drops)

    Completed
    • Primary Open-Angle Glaucoma
    • Ocular Hypertension
    • Artesia, California
    • +9 more
    Mar 22, 2018

    Glaucoma, Ocular Hypertension, Eye Disease Trial in United States (AMA0076, Placebo)

    Completed
    • Glaucoma
    • +2 more
    • Artesia, California
    • +5 more
    Jul 16, 2013

    Ocular Hypertension, Open-Angle Glaucoma, Exfoliation Syndrome Trial in United States (timolol maleate, dorzolamide/timolol

    Completed
    • Ocular Hypertension
    • +3 more
    • timolol maleate
    • dorzolamide/timolol maleate fixed combination
    • Little Rock, Arkansas
    • +4 more
    Nov 18, 2008

    Open-Angle Glaucoma, Ocular Hypertension Trial in Atlanta (Xalatan)

    Completed
    • Open-Angle Glaucoma
    • Ocular Hypertension
    • Atlanta, Georgia
      Atlanta
    Jul 28, 2008

    Glaucoma, Ocular Hypertension Trial in Atlanta (Brimonidine ophthalmic solution 0.1%, Brimonidine ophthalmic solution 0.2%)

    Completed
    • Glaucoma
    • Ocular Hypertension
    • Brimonidine ophthalmic solution 0.1%
    • Brimonidine ophthalmic solution 0.2%
    • Atlanta, Georgia
      (unnamed)
    Apr 1, 2008

    Glaucoma, Ocular Hypertension Trial in Atlanta (latanoprost 0.005% eye drops and brimonidine 0.1% eye drops, latanoprost 0.005%

    Completed
    • Glaucoma
    • Ocular Hypertension
    • latanoprost 0.005% eye drops and brimonidine 0.1% eye drops
    • latanoprost 0.005% eye drops and brinzolamide 1.0% eye drops
    • Atlanta, Georgia
      (unnamed)
    Dec 26, 2007

    Open Angle Glaucoma, Ocular Hypertension, Pseudoexfoliation Syndrome Trial in United States (Travatan, Azopt, Alphagan P)

    Completed
    • Open Angle Glaucoma
    • +2 more
    • Los Angeles, California
    • +20 more
    Feb 22, 2006